InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register account icon
S&P 500
5,504.22
(
-0.73%
)
US TECH 100
19,006.80
(
-0.90%
)
Dow Jones
40,245.72
(
-1.03%
)
Brent Oil
82.21
(
-2.22%
)
Bitcoin
66,349.13
(
3.72%
)

Replies to post #97435 on Biotech Values

Replies to #97435 on Biotech Values
icon url

genisi

06/19/10 6:39 AM

#97461 RE: DewDiligence #97435

Tasigna’s sales will rise of course but I think short term more on the expanse of Sprycel in 2nd line. Anyhow NVS has time to move Tasigna into 1st line before Gleevec goes off patent in 2015.